A generic drug maker Perrigo Co. (PRGO.O) bought the marketing application of KV Pharmaceuticals Inc. (KVa.N) (KVb.N) to market a generic version (GSK.L GlaxoSmithKline ) (GSK.N) Duac acne for a down payment of $ 14 million. Move Perrigo to buy additional new drug application (ANDA) for generic versions..
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment